August Pfluger

Roberto Clemente Commemorative Coin Act

This bill directs the Department of the Treasury to mint and issue coins in recognition of the life of Roberto Clemente, baseball player and human rights activist. All sales of coins issued under this bill must include a surcharge to be paid to the Roberto Clemente Foundation.

Safe Passage on Interstates Act of 2025

This bill establishes a new federal criminal offense for the obstruction of interstate highways.

Specifically, the bill makes it unlawful to knowingly engage in a listed activity with the intent to obstruct the free, convenient, and normal use of the interstate highway. The listed activities are (1) deliberately delaying traffic, (2) standing or approaching a motor vehicle, or (3) endangering the safe movement of a motor vehicle.

A violation is subject to criminal penalties.

The bill provides an exception for any lawful activity conducted or authorized by the federal government or by a state or local government.

Crime Victims Fund Stabilization Act of 2025

This bill adds a new source of revenue for the Crime Victims Fund (CVF). Specifically, the bill requires certain civil monetary penalties collected from settlements and judgments in cases involving fraud and false claims against the federal government to be deposited into the CVF through FY2029.

The CVF supports federal, state, and local programs and activities to compensate and assist victims of crimes. Currently, the CVF is funded by deposits from a variety of sources, including federal criminal fines, penalties, and assessments; forfeited bail bonds; and certain other gifts, donations, and bequests.

Locating Every Disbursement in Government Expenditure Records Act or the LEDGER Act

This bill requires the Department of the Treasury to implement a system that tracks all outlays from each appropriation, receipt, or other fund account in the Treasury by each department, agency, office, or other establishment in the executive, legislative, or judicial branches of the federal government. The system must also track the period of availability of the amounts in the applicable appropriation, receipt, or other fund account.

Improving Seniors' Timely Access to Care Act of 2025

This bill establishes several requirements and standards relating to prior authorization processes under Medicare Advantage (MA) plans.

Specifically, MA plans must (1) establish an electronic prior authorization program that meets specified standards; (2) annually submit to the CMS for publication specified prior authorization information, including the percentage of requests approved and the average response time; and (3) meet other standards, as set by the Centers for Medicare & Medicaid Services (CMS), relating to the quality and timeliness of prior authorization determinations.

The CMS and the Office of the National Coordinator for Health Information Technology must publish on the CMS' website a report that analyzes the information received from MA plans, the feasibility of implementing real-time decision making with respect to prior authorization requests, and the impact of decisions that are made using artificial intelligence on patient access.

Give Kids a Chance Act of 2025

This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research.

Specifically, the bill

• modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met;

• permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement;

• renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and

• reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research.

The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra, a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)

This resolution commends and congratulates Petty Officer Third Class Scott Ruskan for his bravery and heroic efforts to rescue 165 victims during the July 2025 catastrophic flooding in central Texas.

It also extends gratitude to all members of the Coast Guard, other federal and state agencies, first responders, and volunteers who risked their lives to protect and rescue others.

Tren de Aragua Border Security Threat Assessment Act

This bill requires the Department of Homeland Security (DHS) to submit a border threat assessment and strategic plan regarding Tren de Aragua and other transnational criminal organizations. (Tren de Aragua is a gang that originated in Venezuela.)

The threat assessment must include current and potential criminal threats from Tren de Aragua and a description of its origins, strategic aims, funding sources, and U.S. growth and presence.

DHS must submit a strategic plan not later than one year after submission of the threat assessment. The plan must include, for example, a consideration of the threat assessment and mitigation efforts regarding Tren de Aragua and other transnational criminal organizations and efforts to disseminate information between DHS and other departments, agencies, and law enforcement entities with missions associated with the border.

Patient Access to Higher Quality Health Care Act of 2025

This bill repeals provisions under the Stark law (i.e., the Physician Self-Referral Law) that limit, for purposes of Medicare participation, self-referrals by newly constructed or expanded physician-owned hospitals.

Military Spouse Hiring Act

This bill allows employers to claim a tax credit for a percentage of qualified wages paid to an employee who is a military spouse by expanding the federal Work Opportunity Tax Credit (WOTC) to add qualified military spouses as a targeted group. (The WOTC applies to employers who hire members of specific targeted groups, such as veterans, ex-felons, and long-term unemployment recipients, and is generally equal to a percentage of the wages paid to such individuals in the first year of employment, up to a maximum amount. Under current law, the wages must be paid before 2026.)

The bill defines a qualified military spouse as any individual who is certified by a state workforce agency as being (as of the hiring date) a spouse of a member of the Armed Forces.

Protecting Access for Hunters and Anglers Act of 2025

This bill bars the Fish and Wildlife Service (FWS), the Bureau of Land Management (BLM), and the Forest Service from prohibiting or regulating the use of lead ammunition or tackle on federal land or water. The bill makes exceptions for specified existing regulations and where the FWS, the BLM, or the Forest Service determines that a decline in wildlife population at the specific unit of federal land or water is primarily caused by the use of lead in ammunition or tackle, based on the field data from such unit, and the state approves the regulations.

This bill designates the community-based outpatient clinic of the Department of Veterans Affairs in Lubbock, Texas, as the General Bernie Mittemeyer VA Clinic.

Restore Protections for Dialysis Patients Act

This bill specifies certain requirements for private health insurers regarding coverage of individuals with end stage renal disease (ESRD) who are also covered under Medicare.

In particular, the bill specifies that insurers may not limit benefits, including limiting network composition, in a manner that will affect ESRD Medicare beneficiaries differently compared to others without ESRD. The bill additionally specifies that insurers are not required to include a particular renal dialysis provider or a particular number of such providers as part of their networks.